Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 9:7:7-15.
doi: 10.4137/CCRPM.S8140. Print 2013.

Emerging Therapeutic Options for the Management of COPD

Debra J Reid  1 , Nga T Pham
Affiliations

Emerging Therapeutic Options for the Management of COPD

Debra J Reid et al. Clin Med Insights Circ Respir Pulm Med. .

Abstract

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.

Keywords: COPD therapy; chronic obstructive pulmonary disease; long-acting muscarinic agent; long-acting β2-agonist; phosphodiesterase-4 inhibitor.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD (GOLD) 2013. Global Initiative for Chronic Obstructive Lung Disease. [Accessed February 18, 2013]. http://www.goldcopd.org. Updated 2013.
    1. Soriano JB, Lamprecht B. Chronic obstructive pulmonary disease: a worldwide problem. Med Clin North Am. 2012;96(4):671–80. - PubMed
    1. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. The Lancet. 2012;379(9823):1341–51. - PMC - PubMed
    1. Seifart C, Vogelmeier C. Emerging drugs in chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2009;14(1):181–94. - PubMed
    1. Casarosa P, Bouyssou T, Germeyer S, et al. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs. J Pharmacol Exp Ther. 2009;330(2):660–8. - PubMed

LinkOut - more resources